You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
亞盛醫藥(06855.HK)與康聖環球(09960.HK)達成血液腫瘤診療戰略合作
亞盛醫藥-B(06855.HK)與康聖環球(09960.HK)於服貿會上簽署戰略合作備忘錄,未來雙方將加強服務資源與信息資源對接,就臨床試驗中生物標誌物的研究及轉化展開深度合作,並共同探索提升血液腫瘤相關生物標記物檢測方法的可及性。 雙方將在血液病領域達成全面合作,亞盛醫藥表示,與康聖環球的戰略合作,將成為旗下核心產品奧雷巴替尼(Olverembatinib)商業化佈局中的重要一步,推動中國慢性粒細胞白血病(CML)患者的精準化治療。 雙方並將探索提高中國耐藥突變類型T315I檢測的可及性,實現攜T315I突變CML患者的精準篩查,幫助其盡快接受精準有效的藥物治療;並推動CML患者的精準化和個性化治療。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account